scholarly journals Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge

JGH Open ◽  
2020 ◽  
Vol 4 (2) ◽  
pp. 267-272
Author(s):  
Arvind Rajagopalan ◽  
Dharshan Sathananthan ◽  
Yoon‐Kyo An ◽  
Lucinda Van De Ven ◽  
Serena Martin ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Care Patient ◽  
Patient Perceptions ◽  
Gastrointestinal Ultrasound ◽  
Inflammatory Bowel

scholarly journals Systematic Review: Patient Perceptions of Monitoring Tools in Inflammatory Bowel Disease

2020 ◽  
Author(s):  
Thomas M Goodsall ◽  
Richard Noy ◽  
Tran M Nguyen ◽  
Samuel P Costello ◽  
Vipul Jairath ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Disease Activity ◽  
Patient Preference ◽  
Bowel Disease ◽  
Patient Perceptions ◽  
Monitoring Tools ◽  
Ultrasound Computed Tomography ◽  
Gastrointestinal Ultrasound ◽  
Inflammatory Bowel ◽  
Wireless Capsule

Abstract Background and Aims Inflammatory bowel disease (IBD) is a lifelong disease requiring frequent assessment to guide treatment and prevent flares or progression. Multiple tools are available for clinicians to monitor disease activity; however, there are a paucity of data to inform which monitoring tools are most acceptable to patients. The review aims to describe the available evidence for patient preference, satisfaction, tolerance and/or acceptability of the available monitoring tools in adults with IBD. Methods Embase, Medline, Cochrane Central and Clinical Trials.gov were searched from January 1980 to April 2019 for all study types reporting on the perspectives of adults with confirmed IBD on monitoring tools, where two or more tools were compared. Outcome measures with summary and descriptive data were presented. Results In 10 studies evaluating 1846 participants, monitoring tools included venipuncture, stool collection, gastrointestinal ultrasound, computed tomography, magnetic resonance imaging, wireless capsule endoscopy, barium follow-through and endoscopy. Outcome domains were patient satisfaction, acceptability of monitoring tool and patient preference. Noninvasive investigations were preferable to endoscopy in nine studies. When assessed, gastrointestinal ultrasound was consistently associated with greater acceptability and satisfaction compared with endoscopy or other imaging modalities. Conclusions Adults with IBD preferred noninvasive investigations, in particular gastrointestinal ultrasound, as compared to endoscopy for monitoring disease activity. When assessing disease activity, patient perceptions should be considered in the selection of monitoring tools. Further research should address whether adpoting monitoring approaches considered more acceptable to patients results in greater satisfaction, adherence and ultimately more beneficial clinical outcomes.

Sa577 PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

2021 ◽  
Vol 160 (6) ◽  
pp. S-559
Author(s):  
Spyros I. Siakavellas ◽  
Lauranne Derikx ◽  
Lisa M. Derr ◽  
Linda Williams ◽  
Laura Lucaciu ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Patient Perceptions ◽  
Inflammatory Bowel

scholarly journals P430 Feasibility and reliability of gastrointestinal ultrasound in pregnant inflammatory bowel disease patients

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S391-S393
Author(s):  
F de Voogd ◽  
H Joshi ◽  
E Van Wassenaer ◽  
G D’Haens ◽  
K Gecse
Keyword(s):  
Inflammatory Bowel Disease ◽  
Disease Activity ◽  
Terminal Ileum ◽  
Bowel Disease ◽  
Activity Index ◽  
Third Trimester ◽  
Faecal Calprotectin ◽  
Gastrointestinal Ultrasound ◽  
Inflammatory Bowel ◽  
Active Disease

Abstract Background Disease activity during pregnancy in women with inflammatory bowel disease (IBD) is associated with miscarriage, preterm delivery and low birth weight. Monitoring disease activity throughout the pregnancy is therefore important. Gastrointestinal ultrasound (GIUS) has a high potential as a point-of-care tool for monitoring disease activity in IBD as it has been shown to correlate well with endoscopy and magnetic resonance imaging. However, data are scarce on the use of GIUS in IBD throughout pregnancy. The aim of this prospective study is to determine the feasibility and reliability of GIUS in pregnant IBD patients. Methods Patients were included when visiting the outpatient IBD pregnancy clinic. At each trimester, clinical and biochemical disease activity was evaluated and GIUS was performed. Feasibility was assessed by the ability to visualise each bowel segment (terminal ileum (TI), ascending (AC), transverse (TC), descending (DC) and sigmoid colon (SC)). Reliability was evaluated by using clinical and biochemical disease activity as a gold standard. This was defined as a Harvey–Bradshaw Index ≥4 in Crohn’s disease (CD) or a Simple Clinical Colitis Activity Index ≥5 in ulcerative colitis and a faecal calprotectin (FCP)³ 250 mg/g. Bowel wall thickness (BWT) of > 3 mm in the colon and > 2mm in the terminal ileum was considered as signs of active inflammation on ultrasound. A Mann–Whitney U-test and chi-square were used for statistical analysis. Results Thirty-two IBD patients (54% CD) were studied. Both a GIUS and FCP was available in 18, 11 and 6 patients for the first, second and third trimester, respectively. Eleven of 32 (34%) patients had clinically active disease at least at one time point during the pregnancy. Table 1 shows the visibility per segment. When the active disease was defined as an FCP ≥ 250 mg/g, GIUS could distinguish active from the non-active disease in the first, second and third trimester with a sensitivity of 80%, 75% and 75% and specificity of 85%, 86% and 100%, respectively. FCP levels were significantly higher in patients with an active disease on GIUS regardless of the trimester (mean 1095.5 ± 1453.8 mg/g vs. 265.25 ± 649.8 mg/g, p < 0.0001). Conclusion GIUS is accurate to distinguish active from the quiescent disease in pregnancy. Feasibility to visualise the TI and the SC decreased during the second and third trimester, although active disease could still be detected. Consequently, GIUS is feasible and reliable to assess disease activity throughout pregnancy in IBD.

Su1410 Patient Perceptions on the Impact of Coffee Consumption in Inflammatory Bowel Disease: Friend or Foe?

2014 ◽  
Vol 146 (5) ◽  
pp. S-462
Author(s):  
Christiane Barthel ◽  
Sandra Wiegand ◽  
Sylvie Scharl ◽  
Michael Scharl ◽  
Pascal Frei ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Coffee Consumption ◽  
Patient Perceptions ◽  
Inflammatory Bowel ◽  
The Impact

scholarly journals Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Isabelle Noiseux ◽  
Sophie Veilleux ◽  
Alain Bitton ◽  
Rita Kohen ◽  
Luc Vachon ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Inflammatory Bowel Disease Patient ◽  
Disease Patient ◽  
Patient Perceptions ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document